ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Biological E. to begin Phase III trial of COVID-19 vaccine expresspharma
May 10, 2021Biological E. will soon start Phase III trials of its COVID-19 vaccine and plans to produce 75 million to 80 million doses a month from August, its managing director told Reuters. -
Biological E. acquires Akorn India expresspharma
August 18, 2020The timing of this acquisition is fortuitous as it will immediately allow us to expand our capacity to manufacture our investigational COVID-19 vaccine, said the company.
Pharma Sources Insight January 2025
